Data as of Apr 17
| +0.27 / +0.70%|
The 13 analysts offering 12-month price forecasts for Seattle Genetics Inc have a median target of 48.00, with a high estimate of 65.00 and a low estimate of 24.00. The median estimate represents a +23.58% increase from the last price of 38.84.
The current consensus among 15 polled investment analysts is to Buy stock in Seattle Genetics Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.